{
    "body": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19439414", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20459070", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23425245", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21262074", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22489623", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16302972", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18572189", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18285522", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20566645", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19506933", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24260207", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22815480"
    ], 
    "ideal_answer": [
        "The following mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy: L29Q; A8V; A31S; E134D; c.363dupG; A23Q; D145E and C84Y"
    ], 
    "exact_answer": [
        [
            "L29Q"
        ], 
        [
            "A8V"
        ], 
        [
            "A31S"
        ], 
        [
            "E134D"
        ], 
        [
            "c.363dupG"
        ], 
        [
            "A23Q"
        ], 
        [
            "D145E"
        ], 
        [
            "C84Y"
        ]
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002312", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019209", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009154"
    ], 
    "type": "list", 
    "id": "5314a7a4dae131f847000003", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 214, 
            "text": "The Ca(2+) binding properties of the FHC-associated cardiac troponin C (cTnC) mutation L29Q were examined in isolated cTnC, troponin complexes, reconstituted thin filament preparations, and skinned cardiomyocytes. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24260207", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 198, 
            "text": "Effects of calcium binding and the hypertrophic cardiomyopathy A8V mutation on the dynamic equilibrium between closed and open conformations of the regulatory N-domain of isolated cardiac troponin C", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23425245", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1489, 
            "offsetInEndSection": 1644, 
            "text": "We also used PRE data to assess the structural effects of a familial hypertrophic cardiomyopathy point mutation located within the N-domain of cTnC (A8V). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23425245", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 132, 
            "text": "A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815480", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 259, 
            "offsetInEndSection": 471, 
            "text": "Here, we report clinical and functional characterization of a novel TNNC1 mutation, A31S, identified in a pediatric HCM proband with multiple episodes of ventricular fibrillation and aborted sudden cardiac death.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815480", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1580, 
            "offsetInEndSection": 1758, 
            "text": "In summary, we report a novel mutation in the TNNC1 gene that is associated with HCM pathogenesis and may predispose to the pathogenesis of a fatal arrhythmogenic subtype of HCM.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815480", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 277, 
            "text": "The objective of this work was to investigate the effect of hypertrophic cardiomyopathy-linked A8V and E134D mutations in cardiac troponin C (cTnC) on the response of reconstituted thin filaments to calcium upon phosphorylation of cardiac troponin I (cTnI) by protein kinase A.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22489623", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 311, 
            "offsetInEndSection": 418, 
            "text": "We describe a novel type of mutation (c.363dupG) in Troponin C, a rare form of hypertrophic cardiomyopathy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21262074", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 756, 
            "offsetInEndSection": 1030, 
            "text": "We report the first frameshift mutation (c.363dupG or p.Gln122AlafsX30) in Troponin C causing hypertrophic cardiomyopathy (and sudden cardiac death) in a 19-year-old male, and have demonstrated that the mutation segregates with hypertrophic cardiomyopathy within the family.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21262074", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 584, 
            "offsetInEndSection": 716, 
            "text": "One mutant (A23Q) was found with HCM-like properties (increased Ca(2+) sensitivity of force and normal levels of ATPase inhibition).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20566645", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 110, 
            "offsetInEndSection": 285, 
            "text": "In this study, we investigated the effects of hypertrophic cardiomyopathy-linked mutations A8V, E134D, and D145E in cardiac troponin C on the properties of the C-domain sites.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20459070", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 209, 
            "text": "Recently four new hypertrophic cardiomyopathy mutations in cardiac troponin C (cTnC) (A8V, C84Y, E134D, and D145E) were reported, and their effects on the Ca(2+) sensitivity of force development were evaluated", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19439414", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 770, 
            "offsetInEndSection": 987, 
            "text": "Comprehensive open reading frame/splice site mutation analysis of TNNC1 performed on 1025 unrelated HCM patients enrolled over the last 10 years revealed novel missense mutations in TNNC1: A8V, C84Y, E134D, and D145E.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18572189", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 116, 
            "text": "The cardiac troponin C (cTnC) mutation, L29Q, has been found in a patient with familial hypertrophic cardiomyopathy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18285522", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1666, 
            "offsetInEndSection": 1858, 
            "text": "These results demonstrate that the L29Q mutation enhances the Ca(2+)-binding characteristics of cTnC and that when incorporated into cardiac myocytes, this mutant alters myocyte contractility.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18285522", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 176, 
            "text": "Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16302972", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 304, 
            "offsetInEndSection": 422, 
            "text": "This mutation leads to a leucine-glutamine exchange at position 29 in the nonfunctional calcium-binding site of cTnC. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16302972", 
            "endSection": "abstract"
        }
    ]
}